Navigator vs Standard Needle Injection for Hip

Inclusion criteria

• Males and females, ≥18 years of age, of any race or ethnicity;
• Capable of completing self-administered questionnaires;
• Patients with suspected intra-articular hip pain who have failed conservative care (conservative care defined as a standard regimen of home or outpatient physical therapy, activity modification, trial of at least one NSAID) for at least 3 months;
• Candidate for a hip injection;
• Have been informed of the nature of the study, agreeing to its requirements, and have signed the informed consent approved by the Institutional Review Board/Ethics Committee.
• Subjects are able to understand and speak English

Exclusion criteria

• History of intra-articular injection within the last 3 months prior to the injection procedure;
• Complex regional pain syndrome;
• History of prior hip surgery;
• History of substance abuse;
• Known history of hypersensitivity to local anesthetics of the amide type;
• Contraindicated for Celestone (betamethasone sodium phosphate);
• Contraindicated for Lidocaine Hydrochloride;
• Is a prisoner or ward of the state;
• Are unable to meet the treatment and follow up protocol requirements.